1. How should we assess the clinical and cost effectiveness of histology independent cancer drugs?. (2nd January 2020) Authors: Cooper, Sophie; Bouvy, Jacoline C; Baker, Lawrence; Maignen, Francois; Jonsson, Pall; Clark, Peter; Palmer, Stephen; Boysen, Meindert; Crabb, Nick Journal: BMJ Issue: Volume 368(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Value for money of drug regulation. (June 2012) Authors: Bouvy, Jacoline C; Koopmanschap, Marc A; Schellekens, Huub Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 12:Number 3(2012) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Value for money of drug regulation. (June 2012) Authors: Bouvy, Jacoline C; Koopmanschap, Marc A; Schellekens, Huub Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 12:Number 3(2012) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Value for money of drug regulation. (June 2012) Authors: Bouvy, Jacoline C; Koopmanschap, Marc A; Schellekens, Huub Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 12:Number 3(2012) Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗